Formosa Pharmaceuticals Investors
Financials
Consolidated Financial Statements
News Highlight
Formosa Pharmaceuticals completes USD $21.1 million fundraising and increase in cash capital
April 16, 2021
April 16, 2021 Formosa Pharmaceuticals (FP), a subsidiary of Formosa Laboratories (TWSE 4746), hassuccessfully completed a Series C financing round, increasing its cash capital by NTD $600million (approx. USD $21.1